Protalix BioTherapeutics, Inc. (PLX) Q3 2025 Earnings Call Transcript
Source: SeekingAlpha
2025-11-13 10:11:45 ET
Protalix BioTherapeutics, Inc. (PLX) Q3 2025 Earnings Call November 13, 2025 8:00 AM EST...
Read the full article on Seeking Alpha
For further details see:
Protalix BioTherapeutics, Inc. (PLX) Q3 2025 Earnings Call Transcript
Protalix BioTherapeutics Inc.
NASDAQ: PLX
PLX Trading
0.56% G/L:
$2.70 Last:
175,005 Volume:
$2.70 Open:
PLX Latest News
January 30, 2026 09:47:43 am
Chiesi Global Rare Diseases and Protalix BioTherapeutics Receive Positive CHMP Opinion for an Additional Dosing Regimen of Every Four Weeks for Elfabrio® (pegunigalsidase alfa) in the EU
December 17, 2025 06:50:00 am
Protalix Biotherapeutics and Secarna Pharmaceuticals Enter into Collaboration and Option Agreement
November 13, 2025 06:50:00 am
Protalix BioTherapeutics Reports Third Quarter 2025 Financial and Business Results
PLX Stock Data
$215,126,659
70,448,955
0.23%
25
N/A
Biotechnology & Life Sciences
Healthcare
US
Hackensack
